CRISPR therapies
Coverage of CRISPR therapies in the Nexus archive.
- STAT+: Startup promising to scale custom CRISPR therapies abruptly scraps plans
Aurora Therapeutics, a startup focused on personalized gene-editing drugs, has scrapped its lead program and reduced staff, reportedly due to competition from Beam Therapeutics, which advanced similar therapies for the same disease.
- Personalized CRISPR therapies could soon reach thousands — here’s how
A new approach to trialing CRISPR therapies for rare genetic diseases could make their production economically viable, potentially enabling treatment for thousands. The study, published in Nature, highlights advancements in personalized medicine for genetic disorders.
- Daily briefing: Should we worry about AI doomsday?
The article discusses researchers' perspectives on the validity and risks of AI doomsday scenarios, alongside updates on a social network for agentic AI bots and advancements in personalized CRISPR therapies to expand access.